Follow me on Twitter

I agree that content from Twitter will be displayed to me.

 

Head of Group
Director of Corporate Program

His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.

Contact Hours for Students

  • Wednesday 14:00 - 15:00
  • Room 2E405 (or online) 
  • only after appointment via E-Mail latest on Friday before
Publications

Showing entries 1 - 5 out of 307
Dvorak, V, Casiraghi, A, Colas, C, Koren, A, Tomek, T, Offensperger, F, Rukavina, A, Tin, G, Hahn, E, Dobner, S, Frommelt, F, Boeszoermenyi, A, Bernada, V, Hannich, JT, Ecker, GF, Winter, GE, Kubicek, S & Superti-Furga, G 2023, 'Paralog-dependent isogenic cell assay cascade generates highly selective SLC16A3 inhibitors', Cell Chemical Biology, vol. 30, no. 8, pp. 953-964.e9. https://doi.org/10.1016/j.chembiol.2023.06.029

Activities

Open PHACTS - Exploiting semantically integrated life science data for transporter profiling

Gerhard Ecker
BioMedical Transporters
Conference, Talk or oral contribution
7.8.2017 - 7.8.2017

Leveraging linked open data - from transporter interaction profiling to toxicity prediction and beyond

Gerhard Ecker
11th European Workshop in Drug Design
Seminar/Workshop, Talk or oral contribution
23.5.2017 - 23.5.2017

Innovative Medicines Initiative - From semantic data integration to risk assessment

Gerhard Ecker
253rd ACS National Meeting & Exhibition
Conference, Talk or oral contribution
5.4.2017 - 5.4.2017

Leveraging open data for development of ABC-transporter inhibitors

Gerhard Ecker
Gordon Research Conference on Multi-drug Efflux Systems
Conference, Talk or oral contribution
27.3.2017 - 27.3.2017

Leveraging linked open data - from transporter profiling to toxicity prediction and beyond

Gerhard Ecker
Talk or oral contribution
21.3.2017 - 21.3.2017